Melatonin in drug addiction and addiction management: Exploring an evolving multidimensional relationship
|
摘要
Melatonin is a pleiotropic signalling molecule that regulates several physiological functions, and synchronises biological rhythms. Recent evidences are beginning to reveal that a dysregulation of endogenous melatonin rhythm or action may play a larger role in the aetiology and behavioural expression of drug addiction, than was previously considered. Also, the findings from a number of animal studies suggest that exogenous melatonin supplementation and therapeutic manipulation of melatonin/melatonin receptor interactions may be beneficial in the management of behavioural manifestations of drug addiction. However, repeated exogenous melatonin administration may cause a disruption of its endogenous rhythm and be associated with potential drawbacks that might limit its usefulness. In this review, we examine the roles of melatonin and its receptors in addictive behaviours; discussing how our understanding of melatonin's modulatory effects on the brain rewards system and crucial neurotransmitters such as dopamine has evolved over the years. Possible indications(s) for melatonergic agents in addiction management, and how manipulations of the endogenous melatonin system may be of benefit are also discussed. Finally, the potential impediments to application of melatonin in the management of addictive behaviours are considered.
Melatonin is a pleiotropic signalling molecule that regulates several physiological functions, and synchronises biological rhythms. Recent evidences are beginning to reveal that a dysregulation of endogenous melatonin rhythm or action may play a larger role in the aetiology and behavioural expression of drug addiction, than was previously considered. Also, the findings from a number of animal studies suggest that exogenous melatonin supplementation and therapeutic manipulation of melatonin/melatonin receptor interactions may be beneficial in the management of behavioural manifestations of drug addiction. However, repeated exogenous melatonin administration may cause a disruption of its endogenous rhythm and be associated with potential drawbacks that might limit its usefulness. In this review, we examine the roles of melatonin and its receptors in addictive behaviours; discussing how our understanding of melatonin's modulatory effects on the brain rewards system and crucial neurotransmitters such as dopamine has evolved over the years. Possible indications(s) for melatonergic agents in addiction management, and how manipulations of the endogenous melatonin system may be of benefit are also discussed. Finally, the potential impediments to application of melatonin in the management of addictive behaviours are considered.
Melatonin is a pleiotropic signalling molecule that regulates several physiological functions, and synchronises biological rhythms. Recent evidences are beginning to reveal that a dysregulation of endogenous melatonin rhythm or action may play a larger role in the aetiology and behavioural expression of drug addiction, than was previously considered. Also, the findings from a number of animal studies suggest that exogenous melatonin supplementation and therapeutic manipulation of melatonin/melatonin receptor interactions may be beneficial in the management of behavioural manifestations of drug addiction. However, repeated exogenous melatonin administration may cause a disruption of its endogenous rhythm and be associated with potential drawbacks that might limit its usefulness. In this review, we examine the roles of melatonin and its receptors in addictive behaviours; discussing how our understanding of melatonin's modulatory effects on the brain rewards system and crucial neurotransmitters such as dopamine has evolved over the years. Possible indications(s) for melatonergic agents in addiction management, and how manipulations of the endogenous melatonin system may be of benefit are also discussed. Finally, the potential impediments to application of melatonin in the management of addictive behaviours are considered.
引文
1 Zhou Y,Zhao M,Zhou C,Li R.Sex differences in drug addiction and response to exercise intervention:From human to animal studies.Front Neuroendocrinol 2016;40:24-41[PMID:26182835DOI:10.1016/j.yfrne.2015.07.001]
2 Wakefield JC.DSM-5 substance use disorder:how conceptual missteps weakened the foundations of the addictive disorders field.Acta Psychiatr Scand 2015;132:327-334[PMID:25968656 DOI:10.1111/acps.12446]
3 Gardner EL.Addiction and brain reward and antireward pathways.Adv Psychosom Med 2011;30:22-60[PMID:21508625 DOI:10.1159/000324065]
4 Jones JD,Comer SD.A review of pharmacogenetic studies of substance-related disorders.Drug Alcohol Depend 2015;152:1-14[PMID:25819021 DOI:10.1016/j.drugalcdep.2015.03.003]
5 UNODC:United Nations Office on Drugs and Crimes.International Standards for the Treatment of Drug Use Disorders-Draft for Field Testing 2016.Available from:URL:https://www.unodc.org/documents/commissions/CND/CND_Sessions/CND_59/ECN72016_CRP4_V1601463.pdf
6 Burns L.World Drug Report 2013 United Nations Office on Drugs and Crime.Drug Alcohol Rev 2014;33:216-216[DOI:10.1111/dar.12110]
7 Wingo T,Nesil T,Choi JS,Li MD.Novelty Seeking and Drug Addiction in Humans and Animals:From Behavior to Molecules.J Neuroimmune Pharmacol 2016;11:456-470[PMID:26481371DOI:10.1007/s11481-015-9636-7]
8 Jadidi N,Nakhaee N.Etiology of drug abuse:a narrative analysis.J Addict 2014;2014:352835[PMID:25247105 DOI:10.1155/2014/352835]
9 Volkow ND,Koob GF,Mc Lellan AT.Neurobiologic Advances from the Brain Disease Model of Addiction.N Engl J Med 2016;374:363-371[PMID:26816013 DOI:10.1056/NEJMra1511480]
10 Volkow ND,Morales M.The Brain on Drugs:From Reward to Addiction.Cell 2015;162:712-725[PMID:26276628 DOI:10.1016/j.cell.2015.07.046]
11 Demers CH,Bogdan R,Agrawal A.The Genetics,Neurogenetics and Pharmacogenetics of Addiction.Curr Behav Neurosci Rep 2014;1:33-44[PMID:25045619 DOI:10.1007/s40473-013-0004-8]
12 Volkow ND,Muenke M.The genetics of addiction.Hum Genet 2012;131:773-777[PMID:22562404 DOI:10.1007/s00439-012-1173-3]
13 Logan RW,Williams WP 3rd,Mc Clung CA.Circadian rhythms and addiction:mechanistic insights and future directions.Behav Neurosci2014;128:387-412[PMID:24731209 DOI:10.1037/a0036268]
14 Falcón E,Mc Clung CA.A role for the circadian genes in drug addiction.Neuropharmacology 2009;56 Suppl 1:91-96[PMID:18644396 DOI:10.1016/j.neuropharm.2008.06.054]
15 Conroy DA,Hairston IS,Arnedt JT,Hoffmann RF,Armitage R,Brower KJ.Dim light melatonin onset in alcohol-dependent men and women compared with healthy controls.Chronobiol Int 2012;29:35-42[PMID:22217099 DOI:10.3109/07420528.2011.636852]
16 Lynch WJ,Girgenti MJ,Breslin FJ,Newton SS,Taylor JR.Gene profiling the response to repeated cocaine self-administration in dorsal striatum:a focus on circadian genes.Brain Res 2008;1213:166-177[PMID:18452895 DOI:10.1016/j.brainres.2008.02.106]
17 Trujillo JL,Roberts AJ,Gorman MR.Circadian timing of ethanol exposure exerts enduring effects on subsequent ad libitum consumption in C57 mice.Alcohol Clin Exp Res 2009;33:1286-1293[PMID:19389184 DOI:10.1111/j.1530-0277.2009.00954.x]
18 Webb IC.Circadian Rhythms and Substance Abuse:Chronobiological Considerations for the Treatment of Addiction.Curr Psychiatry Rep2017;19:12[PMID:28188587 DOI:10.1007/s11920-017-0764-z]
19 Roberts DC,Brebner K,Vincler M,Lynch WJ.Patterns of cocaine self-administration in rats produced by various access conditions under a discrete trials procedure.Drug Alcohol Depend 2002;67:291-299[PMID:12127200 DOI:10.1016/S0376-8716(02)00083-2]
20 Abarca C,Albrecht U,Spanagel R.Cocaine sensitization and reward are under the influence of circadian genes and rhythm.Proc Natl Acad Sci USA 2002;99:9026-9030[PMID:12084940 DOI:10.1073/pnas.142039099]
21 Jansen HT,Sergeeva A,Stark G,Sorg BA.Circadian discrimination of reward:evidence for simultaneous yet separable food-and drug-entrained rhythms in the rat.Chronobiol Int 2012;29:454-468[PMID:22475541 DOI:10.3109/07420528.2012.667467]
22 Mohawk JA,Pezuk P,Menaker M.Methamphetamine and dopamine receptor D1 regulate entrainment of murine circadian oscillators.PLo S One 2013;8:e62463[PMID:23626822 DOI:10.1371/journal.pone.0062463]
23 Vengeliene V,Noori HR,Spanagel R.Activation of Melatonin Receptors Reduces Relapse-Like Alcohol Consumption.Neurops-ychopharmacology 2015;40:2897-2906[PMID:25994077 DOI:10.1038/npp.2015.143]
24 Takahashi TT,Vengeliene V,Spanagel R.Melatonin reduces motivation for cocaine self-administration and prevents relapse-like behavior in rats.Psychopharmacology(Berl)2017;234:1741-1748[PMID:28246896 DOI:10.1007/s00213-017-4576-y]
25 World Health Organization.Neuroscience of psychoactive drug use and dependence.WHO,Geneva Switzerland 2004:1-286.Available from:URL:https://www.naabt.org/documents/Neuroscien ce%20of%20psychoactive.pdf
26 Carter A,Hal L W,Capps B,Daglish M.Neurobiological research on addiction:A review of the scientific,public health and social policy Implications for Australia.2009:1-241.Available from:URL:https://www.nationaldrugstrategy.gov.au/
27 Hyman SE,Malenka RC,Nestler EJ.Neural mechanisms of addiction:the role of reward-related learning and memory.Annu Rev Neurosci 2006;29:565-598[PMID:16776597 DOI:10.1146/annurev.neuro.29.051605.113009]
28 Goldstein RZ,Volkow ND.Drug addiction and its underlying neurobiological basis:neuroimaging evidence for the involvement of the frontal cortex.Am J Psychiatry 2002;159:1642-1652[PMID:12359667 DOI:10.1176/appi.ajp.159.10.1642]
29 Koob GF,Le Moal M.Drug abuse:hedonic homeostatic dysregulation.Science 1997;278:52-58[PMID:9311926 DOI:10.1126/science.278.5335.52]
30 Koob GF,Le Moal M.Addiction and the brain antireward system.Annu Rev Psychol 2008;59:29-53[PMID:18154498 DOI:10.1146/annurev.psych.59.103006.093548]
31 Kreek MJ,Koob GF.Drug dependence:stress and dysregulation of brain reward pathways.Drug Alcohol Depend 1998;51:23-47[PMID:9716928 DOI:10.1016/S0376-8716(98)00064-7]
32 Koob G,Kreek MJ.Stress,dysregulation of drug reward path-ways,and the transition to drug dependence.Am J Psychiatry2007;164:1149-1159[PMID:17671276 DOI:10.1176/appi.ajp.2007.05030503]
33 Koob GF,Le Moal M.Neurobiology of addiction.1st ed.New York:Academic Press,2006
34 Wise RA.Dopamine,learning and motivation.Nat Rev Neurosci2004;5:483-494[PMID:15152198 DOI:10.1038/nrn1406]
35 Volkow ND,Li TK.Drug addiction:the neurobiology of behaviour gone awry.Nat Rev Neurosci 2004;5:963-970[PMID:15550951DOI:10.1038/nrn1539]
36 Wise RA.Dopamine and reward:the anhedonia hypothesis 30years on.Neurotox Res 2008;14:169-183[PMID:19073424 DOI:10.1007/BF03033808]
37 Di Chiara G.Nucleus accumbens shell and core dopamine:differential role in behavior and addiction.Behav Brain Res 2002;137:75-114[PMID:12445717 DOI:10.1016/S0166-4328(02)00286-3]
38 van Ree JM,Gerrits MA,Vanderschuren LJ.Opioids,reward and addiction:An encounter of biology,psychology,and medicine.Pharmacol Rev 1999;51:341-396[PMID:10353987]
39 Feltenstein MW,See RE.Potentiation of cue-induced reinstatement of cocaine-seeking in rats by the anxiogenic drug yohimbine.Behav Brain Res 2006;174:1-8[PMID:16920204 DOI:10.1016/j.bbr.2006.06.039]
40 Brauer LH,De Wit H.High dose pimozide does not block amphetamine-induced euphoria in normal volunteers.Pharmacol Biochem Behav 1997;56:265-272[PMID:9050084 DOI:10.1016/S0091-3057(96)00240-7]
41 Goodman A.Neurobiology of addiction.An integrative review.Biochem Pharmacol 2008;75:266-322[PMID:17764663 DOI:10.1016/j.bcp.2007.07.030]
42 Heinz A,Reimold M,Wrase J,Hermann D,Croissant B,Mundle G,Dohmen BM,Braus DF,Schumann G,Machulla HJ,Bares R,Mann K.Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving:a positron emission tomography study using carbon 11-labeled carfentanil.Arch Gen Psychiatry 2005;62:57-64[PMID:15630073DOI:10.1001/archpsyc.62.1.57]
43 Williams TM,Daglish MR,Lingford-Hughes A,Taylor LG,Hammers A,Brooks DJ,Grasby P,Myles JS,Nutt DJ.Brain opioid receptor binding in early abstinence from opioid dependence:positron emission tomography study.Br J Psychiatry 2007;191:63-69[PMID:17602127 DOI:10.1192/bjp.bp.106.031120]
44 Zubieta JK,Gorelick DA,Stauffer R,Ravert HT,Dannals RF,Frost JJ.Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving.Nat Med1996;2:1225-1229[PMID:8898749 DOI:10.1038/nm1196-1225]
45 Kalivas PW,Lalumiere RT,Knackstedt L,Shen H.Glutamate transmission in addiction.Neuropharmacology 2009;56 Suppl 1:169-173[PMID:18675832 DOI:10.1016/j.neuropharm.2008.07.011]
46 Hochhauser M.Chronobiological Factors in Drug Abuse.A.J.Schecter(ed.).Drug Dependence and Alcoholism.New York:Plenum Press,1981:855-864
47 Hasler BP,Smith LJ,Cousins JC,Bootzin RR.Circadian rhythms,sleep,and substance abuse.Sleep Med Rev 2012;16:67-81[PMID:21620743 DOI:10.1016/j.smrv.2011.03.004]
48 Garmabi B,Vousooghi N,Vosough M,Yoonessi A,Bakhtazad A,Zarrindast MR.Effect of circadian rhythm disturbance on morphine preference and addiction in male rats:Involvement of period genes and dopamine D1 receptor.Neuroscience 2016;322:104-114[PMID:26892296 DOI:10.1016/j.neuroscience.2016.02.019]
49 Doyle SE,Feng H,Garber G,Menaker M,Lynch WJ.Effects of circadian disruption on methamphetamine consumption in meth-amphetamine-exposed rats.Psychopharmacology(Berl)2015;232:2169-2179[PMID:25543849 DOI:10.1007/s00213-014-3845-2]
50 Parekh PK,Ozburn AR,Mc Clung CA.Circadian clock genes:effects on dopamine,reward and addiction.Alcohol 2015;49:341-349[PMID:25641765 DOI:10.1016/j.alcohol.2014.09.034]
51 Schierenbeck T,Riemann D,Berger M,Hornyak M.Effect of illicit recreational drugs upon sleep:cocaine,ecstasy and marijuana.Sleep Med Rev 2008;12:381-389[PMID:18313952 DOI:10.1016/j.smrv.2007.12.004]
52 Brower KJ.Alcohol's effects on sleep in alcoholics.Alcohol Res Health 2001;25:110-125[PMID:11584550]
53 Baker TB,Piper ME,Mc Carthy DE,Majeskie MR,Fiore MC.Addiction motivation reformulated:an affective processing model of negative reinforcement.Psychol Rev 2004;111:33-51[PMID:14756584 DOI:10.1037/0033-295X.111.1.33]
54 Thompson PM,Gillin JC,Golshan S,Irwin M.Polygraphic sleep measures differentiate alcoholics and stimulant abusers during short-term abstinence.Biol Psychiatry 1995;38:831-836[PMID:8750043 DOI:10.1016/0006-3223(95)00070-4]
55 Morgan PT,Pace-Schott E,Pittman B,Stickgold R,Malison RT.Normalizing effects of modafinil on sleep in chronic cocaine users.Am J Psychiatry 2010;167:331-340[PMID:20080983 DOI:10.1176/appi.ajp.2009.09050613]
56 Bolla KI,Lesage SR,Gamaldo CE,Neubauer DN,Wang NY,Funderburk FR,Allen RP,David PM,Cadet JL.Polysomnogram changes in marijuana users who report sleep disturbances during prior abstinence.Sleep Med 2010;11:882-889[PMID:20685163DOI:10.1016/j.sleep.2010.02.013]
57 Fraschini F,Cesarani A,Alpini D,Esposti D,Stankov BM.Mela-tonin influences human balance.Biol Signals Recept 1999;8:111-119[PMID:10085472 DOI:10.1159/000014578]
58 Reiter RJ.Melatonin:clinical relevance.Best Pract Res Clin Endocrinol Metab 2003;17:273-285[PMID:12787552 DOI:10.1016/S1521-690X(03)00016-2]
59 Hardeland R,Cardinali DP,Srinivasan V,Spence DW,Brown GM,Pandi-Perumal SR.Melatonin-a pleiotropic,orchestrating regulator molecule.Prog Neurobiol 2011;93:350-384[PMID:21193011DOI:10.1016/j.pneurobio.2010.12.004]
60 Ekmekcioglu C.Melatonin receptors in humans:biological role and clinical relevance.Biomed Pharmacother 2006;60:97-108[PMID:16527442 DOI:10.1016/j.biopha.2006.01.002]
61 Jockers R,Maurice P,Boutin JA,Delagrange P.Melatonin receptors,heterodimerization,signal transduction and binding sites:what's new?Br J Pharmacol 2008;154:1182-1195[PMID:18493248 DOI:10.1038/bjp.2008.184]
62 Pandi-Perumal SR,Trakht I,Srinivasan V,Spence DW,Maestroni GJ,Zisapel N,Cardinali DP.Physiological effects of melatonin:role of melatonin receptors and signal transduction pathways.Prog Neurobiol 2008;85:335-353[PMID:18571301 DOI:10.1016/j.pneurobio.2008.04.001]
63 Habtemariam S,Daglia M,Sureda A,Selamoglu Z,Gulhan MF,Nabavi SM.Melatonin and Respiratory Diseases:A Review.Curr Top Med Chem 2017;17:467-488[PMID:27558675 DOI:10.2174/1568026616666160824120338]
64 Ate?B,Y?lmaz HR,Selamo?lu Z,Iraz M,Y?lmaz?.Melatonin’in?ntestinal?skemi-Reperfüzyonda 6-Fosfoglukonat Dehidrogenaz Aktivitesiüzerine Etkisi.Süleyman Demirelüniversitesi T?p Fakültesi Dergisi 2004;11:8-11
65 Tas U,Ayan M,Sogut E,Kuloglu T,Uysal M,Tanriverdi HI,Senel U,Ozyurt B,Sarsilmaz M.Protective effects of thymoquinone and melatonin on intestinal ischemia-reperfusion injury.Saudi JGastroenterol 2015;21:284-289[PMID:26458854 DOI:10.4103/1319-3767.166203]
66 Kühlwein E,Hauger RL,Irwin MR.Abnormal nocturnal melatonin secretion and disordered sleep in abstinent alcoholics.Biol Psychiatry 2003;54:1437-1443[PMID:14675809 DOI:10.1016/S0006-3223(03)00005-2]
67 Peres R,do Amaral FG,Madrigrano TC,Scialfa JH,Bordin S,Afeche SC,Cipolla-Neto J.Ethanol consumption and pineal melatonin daily profile in rats.Addict Biol 2011;16:580-590[PMID:21635669 DOI:10.1111/j.1369-1600.2011.00342.x]
68 Uz T,Javaid JI,Manev H.Circadian differences in behavioral sensitization to cocaine:putative role of arylalkylamine N-ace-tyltransferase.Life Sci 2002;70:3069-3075[PMID:12138020 DOI:10.1016/S0024-3205(02)01559-X]
69 Kurtuncu M,Arslan AD,Akhisaroglu M,Manev H,Uz T.Invol-vement of the pineal gland in diurnal cocaine reward in mice.Eur JPharmacol 2004;489:203-205[PMID:15087244 DOI:10.1016/j.ejphar.2004.03.010]
70 Williams RL,Soliman KF,Mizinga KM.Circadian variation in tolerance to the hypothermic action of CNS drugs.Pharmacol Biochem Behav 1993;46:283-288[PMID:8265682 DOI:10.1016/0091-3057(93)90354-V]
71 Drummond SP,Gillin JC,Smith TL,De Modena A.The sleep of abstinent pure primary alcoholic patients:natural course and relationship to relapse.Alcohol Clin Exp Res 1998;22:1796-1802[PMID:9835298 DOI:10.1097/00000374-199811000-00026]
72 Lax P.Melatonin inhibits nicotinic currents in cultured rat cerebellar granule neurons.J Pineal Res 2008;44:70-77[PMID:18078451DOI:10.1111/j.1600-079X.2007.00481.x]
73 Markus RP,Santos JM,Zago W,Reno LA.Melatonin nocturnal surge modulates nicotinic receptors and nicotine-induced[3H]glutamate release in rat cerebellum slices.J Pharmacol Exp Ther 2003;305:525-530[PMID:12606693 DOI:10.1124/jpet.102.045625]
74 Onaolapo OJ,Onaolapo AY.Melatonin,adolescence,and the brain:An insight into the period-specific influences of a multifunctional signaling molecule.Birth Defects Res 2017;109:1659-1671[PMID:29251845 DOI:10.1002/bdr2.1171]
75 Onaolapo OJ,Onaolapo AY.Chapter 4.Melatonin Receptors,Behaviour and Brain Function.Lore Correia and Germaine Mayers(Eds)in Melatonin:Medical Uses and Role in Health and Disease2018:133-158
76 Uz T,Arslan AD,Kurtuncu M,Imbesi M,Akhisaroglu M,Dwivedi Y,Pandey GN,Manev H.The regional and cellular expression profile of the melatonin receptor MT1 in the central dopaminergic system.Brain Res Mol Brain Res 2005;136:45-53[PMID:15893586 DOI:10.1016/j.molbrainres.2005.01.002]
77 Noori HR,Spanagel R,Hansson AC.Neurocircuitry for modeling drug effects.Addict Biol 2012;17:827-864[PMID:22978651 DOI:10.1111/j.1369-1600.2012.00485.x]
78 Imbesi M,Uz T,Yildiz S,Arslan AD,Manev H.Drug-and region-specific effects of protracted antidepressant and cocaine treatment on the content of melatonin MT(1)and MT(2)receptor m RNA in the mouse brain.Int J Neuroprot Neuroregener 2006;2:185-189[PMID:18389085]
79 Hutchinson AJ,Hudson RL,Dubocovich ML.Genetic deletion of MT(1)and MT(2)melatonin receptors differentially abrogates the development and expression of methamphetamine-induced locomotor sensitization during the day and the night in C3H/He Nmice.J Pineal Res 2012;53:399-409[PMID:22672659 DOI:10.1111/j.1600-079X.2012.01010.x]
80 Clough SJ,Hutchinson AJ,Hudson RL,Dubocovich ML.Genetic deletion of the MT1 or MT2 melatonin receptors abrogates methamphetamine-induced reward in C3H/He N mice.Physiol Behav 2014;132:79-86[PMID:24813704 DOI:10.1016/j.ph-ysbeh.2014.04.049]
81 Hutchinson AJ,Ma J,Liu J,Hudson RL,Dubocovich ML.Role of MT1 melatonin receptors in methamphetamine-induced locomotor sensitization in C57BL/6 mice.Psychopharmacology(Berl)2014;231:257-267[PMID:23934259 DOI:10.1007/s00213-013-3228-0]
82 Zahn PK,Lansmann T,Berger E,Speckmann EJ,Musshoff U.Gene expression and functional characterization of melatonin receptors in the spinal cord of the rat:implications for pain modulation.JPineal Res 2003;35:24-31[PMID:12823610 DOI:10.1034/j.1600-079X.2003.00047.x]
83 Sinha R.New findings on biological factors predicting addiction relapse vulnerability.Curr Psychiatry Rep 2011;13:398-405[PMID:21792580 DOI:10.1007/s11920-011-0224-0]
84 Feng YM,Jia YF,Su LY,Wang D,Lv L,Xu L,Yao YG.Decreased mitochondrial DNA copy number in the hippocampus and peripheral blood during opiate addiction is mediated by autophagy and can be salvaged by melatonin.Autophagy 2013;9:1395-1406[PMID:23800874 DOI:10.4161/auto.25468]
85 Sircar R.Effect of melatonin on cocaine-induced behavioral sensitization.Brain Res 2000;857:295-299[PMID:10700581 DOI:10.1016/S0006-8993(99)02460-9]
86 Peles E,Hetzroni T,Bar-Hamburger R,Adelson M,Schreiber S.Melatonin for perceived sleep disturbances associated with benzodiazepine withdrawal among patients in methadone mai-ntenance treatment:a double-blind randomized clinical trial.Addiction 2007;102:1947-1953[PMID:17916225 DOI:10.1111/j.1360-0443.2007.02007.x]
87 Dimsdale JE,Norman D,De Jardin D,Wallace MS.The effect of opioids on sleep architecture.J Clin Sleep Med 2007;3:33-36[PMID:17557450]
88 Wang Q,Yue XF,Qu WM,Tan R,Zheng P,Urade Y,Huang ZL.Morphine inhibits sleep-promoting neurons in the ventrolateral preoptic area via mu receptors and induces wakefulness in rats.Neuropsychopharmacology 2013;38:791-801[PMID:23303062DOI:10.1038/npp.2012.244]
89 Licata SC,Renshaw PF.Neurochemistry of drug action:insights from proton magnetic resonance spectroscopic imaging and their relevance to addiction.Ann N Y Acad Sci 2010;1187:148-171[PMID:20201852 DOI:10.1111/j.1749-6632.2009.05143.x]
90 Gossop M,Bradley B,Phillips GT.An investigation of withdrawal symptoms shown by opiate addicts during and subsequent to a 21-day in-patient methadone detoxification procedure.Addict Behav 1987;12:1-6[PMID:3565107 DOI:10.1016/0306-4603(87)90002-5]
91 Pjrek E,Frey R,Naderi-Heiden A,Strnad A,Kowarik A,Kasper S,Winkler D.Actigraphic measurements in opioid detoxification with methadone or buprenorphine.J Clin Psychopharmacol 2012;32:75-82[PMID:22198453 DOI:10.1097/JCP.0b013e31823f91d1]
92 Hood S,Cassidy P,Mathewson S,Stewart J,Amir S.Daily morphine injection and withdrawal disrupt 24-h wheel running and PERIOD2 expression patterns in the rat limbic forebrain.Neuroscience 2011;186:65-75[PMID:21536108 DOI:10.1016/j.neuroscience.2011.04.045]
93 Glaser AM,Reyes-Vázquez C,Prieto-Gómez B,Burau K,Dafny N.Morphine administration and abrupt cessation alter the behavioral diurnal activity pattern.Pharmacol Biochem Behav 2012;101:544-552[PMID:22386964 DOI:10.1016/j.pbb.2012.02.015]
94 Li SX,Liu LJ,Jiang WG,Lu L.Morphine withdrawal produces circadian rhythm alterations of clock genes in mesolimbic brain areas and peripheral blood mononuclear cells in rats.J Neu-rochem 2009;109:1668-1679[PMID:19383088 DOI:10.1111/j.1471-4159.2009.06086.x]
95 Li SX,Liu LJ,Jiang WG,Sun LL,Zhou SJ,Le Foll B,Zhang XY,Kosten TR,Lu L.Circadian alteration in neurobiology during protr-acted opiate withdrawal in rats.J Neurochem 2010;115:353-362[PMID:20738730 DOI:10.1111/j.1471-4159.2010.06941.x]
96 Zhdanova IV,Giorgetti M.Melatonin alters behavior and c AMPlevels in nucleus accumbens induced by cocaine treatment.Brain Res 2002;956:323-331[PMID:12445702 DOI:10.1016/S0006-8993(02)03565-5]
97 Bondi CD,Kamal KM,Johnson DA,Witt-Enderby PA,Giannetti VJ.The Effect of Melatonin Upon Postacute Withdrawal Among Males in a Residential Treatment Program(M-PAWS):A Randomized,Double-blind,Placebo-controlled Trial.J Addict Med 2018;12:201-206[PMID:29351138 DOI:10.1097/ADM.0000000000000386]
98 Cemek M,Büyükokuro?lu ME,Hazman?,Bulut S,Konuk M,Birdane Y.Antioxidant enzyme and element status in heroin addiction or heroin withdrawal in rats:effect of melatonin and vitamin E plus Se.Biol Trace Elem Res 2011;139:41-54[PMID:20180043 DOI:10.1007/s12011-010-8634-0]
99 O'Brien CP.Anticraving medications for relapse prevention:a possible new class of psychoactive medications.Am J Psychiatry2005;162:1423-1431[PMID:16055763 DOI:10.1176/appi.ajp.162.8.1423]
100 Kalivas PW,O'Brien C.Drug addiction as a pathology of staged neuroplasticity.Neuropsychopharmacology 2008;33:166-180[PMID:17805308 DOI:10.1038/sj.npp.1301564]
101 Sinha R,Shaham Y,Heilig M.Translational and reverse tran-slational research on the role of stress in drug craving and relapse.Psychopharmacology(Berl)2011;218:69-82[PMID:21494792DOI:10.1007/s00213-011-2263-y]
102 Sinha R.How does stress increase risk of drug abuse and relapse?Psychopharmacology(Berl)2001;158:343-359[PMID:11797055DOI:10.1007/s002130100917]
103 Jaffe JH,Cascella NG,Kumor KM,Sherer MA.Cocaine-induced cocaine craving.Psychopharmacology(Berl)1989;97:59-64[PMID:2496428 DOI:10.1007/BF00443414]
104 O’Brien CP,Ehrman RN,Ternes JW.Classical conditioning in human opioid dependence.In:Behavioral analysis of drug dependence(Goldberg S,Stolerman I,eds).Orlando,FL:Academic,1986:329-356
105 Wikler A.Dynamics of drug dependence.Implications of a conditioning theory for research and treatment.Arch Gen Psy-chiatry 1973;28:611-616[PMID:4700675 DOI:10.1001/arc-hpsyc.1973.01750350005001]
106 Bossert JM,Marchant NJ,Calu DJ,Shaham Y.The reinstatement model of drug relapse:recent neurobiological findings,emerging research topics,and translational research.Psychopharmacology(Berl)2013;229:453-476[PMID:23685858 DOI:10.1007/s00213-013-3120-y]
107 Mantsch JR,Baker DA,Funk D,LêAD,Shaham Y.Stress-Induced Reinstatement of Drug Seeking:20 Years of Progress.Neuropsychopharmacology 2016;41:335-356[PMID:25976297DOI:10.1038/npp.2015.142]
108 Dong Y,Taylor JR,Wolf ME,Shaham Y.Circuit and Synaptic Plasticity Mechanisms of Drug Relapse.J Neurosci 2017;37:10867-10876[PMID:29118216 DOI:10.1523/JNEUROSCI.1821-17.2017]
109 Bhargava HN,Kumar S.Sensitization to the locomotor stimulant activity of cocaine is associated with increases in nitric oxide synthase activity in brain regions and spinal cord of mice.Pharmacology 1997;55:292-298[PMID:9413858 DOI:10.1159/000139541]
110 Itzhak Y,Martin JL,Black MD,Ali SF.Effect of melatonin on methamphetamine-and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity and methamphetamine-induced behavioral sensitization.Neuropharmacology 1998;37:781-791[PMID:9707292 DOI:10.1016/S0028-3908(98)00067-7]
111 Patkar AA,Rozen S,Mannelli P,Matson W,Pae CU,Krishnan KR,Kaddurah-Daouk R.Alterations in tryptophan and purine metabolism in cocaine addiction:a metabolomic study.Psychopharmacology(Berl)2009;206:479-489[PMID:19649617 DOI:10.1007/s00213-009-1625-1]
112 Cunha-Oliveira T,Rego AC,Garrido J,Borges F,Macedo T,Oliveira CR.Street heroin induces mitochondrial dysfunction and apoptosis in rat cortical neurons.J Neurochem 2007;101:543-554[PMID:17250679 DOI:10.1111/j.1471-4159.2006.04406.x]
113 Lin X,Wang YJ,Li Q,Hou YY,Hong MH,Cao YL,Chi ZQ,Liu JG.Chronic high-dose morphine treatment promotes SH-SY5Ycell apoptosis via c-Jun N-terminal kinase-mediated activation of mitochondria-dependent pathway.FEBS J 2009;276:2022-2036[PMID:19292871 DOI:10.1111/j.1742-4658.2009.06938.x]
114 Cunha-Oliveira T,Rego AC,Oliveira CR.Cellular and molec-ular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs.Brain Res Rev 2008;58:192-208[PMID:18440072 DOI:10.1016/j.brainresrev.2008.03.002]
115 Bolla KI,Lesage SR,Gamaldo CE,Neubauer DN,Funderburk FR,Cadet JL,David PM,Verdejo-Garcia A,Benbrook AR.Sleep disturbance in heavy marijuana users.Sleep 2008;31:901-908[PMID:18548836 DOI:10.1093/sleep/31.6.901]
116 Brower KJ,Conroy DA,Kurth ME,Anderson BJ,Stein MD.Ramelteon and improved insomnia in alcohol-dependent patients:a case series.J Clin Sleep Med 2011;7:274-275[PMID:21677897DOI:10.5664/JCSM.1070]
117 Roehrs T,Roth T.Sleep,sleepiness,sleep disorders and alcohol use and abuse.Sleep Med Rev 2001;5:287-297[PMID:12530993 DOI:10.1053/smrv.2001.0162]
118 Colrain IM,Trinder J,Swan GE.The impact of smoking cessation on objective and subjective markers of sleep:review,synthesis,and recommendations.Nicotine Tob Res 2004;6:913-925[PMID:15801567 DOI:10.1080/14622200412331324938]
119 Schreiber S.[Benzodiazepines--update].Harefuah 1993;125:172-174[PMID:7901131]
120 Clasadonte J,Mc Iver SR,Schmitt LI,Halassa MM,Haydon PG.Chronic sleep restriction disrupts sleep homeostasis and behavioral sensitivity to alcohol by reducing the extracellular accumulation of adenosine.J Neurosci 2014;34:1879-1891[PMID:24478367 DOI:10.1523/JNEUROSCI.2870-12.2014]
121 Comasco E,Nordquist N,G?ktürk C,Aslund C,Hallman J,Oreland L,Nilsson KW.The clock gene PER2 and sleep problems:association with alcohol consumption among Swedish adolescents.Ups J Med Sci 2010;115:41-48[PMID:20187847 DOI:10.3109/03009731003597127]
122 Spanagel R,Rosenwasser AM,Schumann G,Sarkar DK.Alcohol consumption and the body's biological clock.Alcohol Clin Exp Res 2005;29:1550-1557[PMID:16156052 DOI:10.1097/01.alc.0000175074.70807.fd]
123 Wang X,Mozhui K,Li Z,Mulligan MK,Ingels JF,Zhou X,Hori RT,Chen H,Cook MN,Williams RW,Lu L.A promoter polymorphism in the Per3 gene is associated with alcohol and stress response.Transl Psychiatry 2012;2:e73[PMID:22832735 DOI:10.1038/tp.2011.71]
124 Cajochen C,Kr?uchi K,Wirz-Justice A.Role of melatonin in the regulation of human circadian rhythms and sleep.J Neu-roendocrinol 2003;15:432-437[PMID:12622846 DOI:10.1046/j.1365-2826.2003.00989.x]
125 Shamir E,Laudon M,Barak Y,Anis Y,Rotenberg V,Elizur A,Zisapel N.Melatonin improves sleep quality of patients with chronic schizophrenia.J Clin Psychiatry 2000;61:373-377[PMID:10847313 DOI:10.4088/JCP.v61n0509]
126 Garfinkel D,Laudon M,Nof D,Zisapel N.Improvement of sleep quality in elderly people by controlled-release melatonin.Lancet 1995;346:541-544[PMID:7658780 DOI:10.1016/S0140-6736(95)91382-3]
127 Garfinkel D,Zisapel N,Wainstein J,Laudon M.Facilitation of benzodiazepine discontinuation by melatonin:a new clinical approach.Arch Intern Med 1999;159:2456-2460[PMID:10665894DOI:10.1001/archinte.159.20.2456]
128 Smits MG,Nagtegaal EE,van der Heijden J,Coenen AM,Kerkhof GA.Melatonin for chronic sleep onset insomnia in children:a randomized placebo-controlled trial.J Child Neurol 2001;16:86-92[PMID:11292231 DOI:10.1177/088307380101600204]
129 Wetterberg L,Aperia B,Gorelick DA,Gwirtzman HE,Mc Guire MT,Serafetinides EA,Yuwiler A.Age,alcoholism and depression are associated with low levels of urinary melatonin.J Psychiatry Neurosci 1992;17:215-224[PMID:1489763]
130 Grosshans M,Mutschler J,Luderer M,Mann K,Kiefer F.Agomelatine is effective in reducing insomnia in abstinent alcohol-dependent patients.Clin Neuropharmacol 2014;37:6-8[PMID:24434525 DOI:10.1097/WNF.0000000000000007]
2 Wakefield JC.DSM-5 substance use disorder:how conceptual missteps weakened the foundations of the addictive disorders field.Acta Psychiatr Scand 2015;132:327-334[PMID:25968656 DOI:10.1111/acps.12446]
3 Gardner EL.Addiction and brain reward and antireward pathways.Adv Psychosom Med 2011;30:22-60[PMID:21508625 DOI:10.1159/000324065]
4 Jones JD,Comer SD.A review of pharmacogenetic studies of substance-related disorders.Drug Alcohol Depend 2015;152:1-14[PMID:25819021 DOI:10.1016/j.drugalcdep.2015.03.003]
5 UNODC:United Nations Office on Drugs and Crimes.International Standards for the Treatment of Drug Use Disorders-Draft for Field Testing 2016.Available from:URL:https://www.unodc.org/documents/commissions/CND/CND_Sessions/CND_59/ECN72016_CRP4_V1601463.pdf
6 Burns L.World Drug Report 2013 United Nations Office on Drugs and Crime.Drug Alcohol Rev 2014;33:216-216[DOI:10.1111/dar.12110]
7 Wingo T,Nesil T,Choi JS,Li MD.Novelty Seeking and Drug Addiction in Humans and Animals:From Behavior to Molecules.J Neuroimmune Pharmacol 2016;11:456-470[PMID:26481371DOI:10.1007/s11481-015-9636-7]
8 Jadidi N,Nakhaee N.Etiology of drug abuse:a narrative analysis.J Addict 2014;2014:352835[PMID:25247105 DOI:10.1155/2014/352835]
9 Volkow ND,Koob GF,Mc Lellan AT.Neurobiologic Advances from the Brain Disease Model of Addiction.N Engl J Med 2016;374:363-371[PMID:26816013 DOI:10.1056/NEJMra1511480]
10 Volkow ND,Morales M.The Brain on Drugs:From Reward to Addiction.Cell 2015;162:712-725[PMID:26276628 DOI:10.1016/j.cell.2015.07.046]
11 Demers CH,Bogdan R,Agrawal A.The Genetics,Neurogenetics and Pharmacogenetics of Addiction.Curr Behav Neurosci Rep 2014;1:33-44[PMID:25045619 DOI:10.1007/s40473-013-0004-8]
12 Volkow ND,Muenke M.The genetics of addiction.Hum Genet 2012;131:773-777[PMID:22562404 DOI:10.1007/s00439-012-1173-3]
13 Logan RW,Williams WP 3rd,Mc Clung CA.Circadian rhythms and addiction:mechanistic insights and future directions.Behav Neurosci2014;128:387-412[PMID:24731209 DOI:10.1037/a0036268]
14 Falcón E,Mc Clung CA.A role for the circadian genes in drug addiction.Neuropharmacology 2009;56 Suppl 1:91-96[PMID:18644396 DOI:10.1016/j.neuropharm.2008.06.054]
15 Conroy DA,Hairston IS,Arnedt JT,Hoffmann RF,Armitage R,Brower KJ.Dim light melatonin onset in alcohol-dependent men and women compared with healthy controls.Chronobiol Int 2012;29:35-42[PMID:22217099 DOI:10.3109/07420528.2011.636852]
16 Lynch WJ,Girgenti MJ,Breslin FJ,Newton SS,Taylor JR.Gene profiling the response to repeated cocaine self-administration in dorsal striatum:a focus on circadian genes.Brain Res 2008;1213:166-177[PMID:18452895 DOI:10.1016/j.brainres.2008.02.106]
17 Trujillo JL,Roberts AJ,Gorman MR.Circadian timing of ethanol exposure exerts enduring effects on subsequent ad libitum consumption in C57 mice.Alcohol Clin Exp Res 2009;33:1286-1293[PMID:19389184 DOI:10.1111/j.1530-0277.2009.00954.x]
18 Webb IC.Circadian Rhythms and Substance Abuse:Chronobiological Considerations for the Treatment of Addiction.Curr Psychiatry Rep2017;19:12[PMID:28188587 DOI:10.1007/s11920-017-0764-z]
19 Roberts DC,Brebner K,Vincler M,Lynch WJ.Patterns of cocaine self-administration in rats produced by various access conditions under a discrete trials procedure.Drug Alcohol Depend 2002;67:291-299[PMID:12127200 DOI:10.1016/S0376-8716(02)00083-2]
20 Abarca C,Albrecht U,Spanagel R.Cocaine sensitization and reward are under the influence of circadian genes and rhythm.Proc Natl Acad Sci USA 2002;99:9026-9030[PMID:12084940 DOI:10.1073/pnas.142039099]
21 Jansen HT,Sergeeva A,Stark G,Sorg BA.Circadian discrimination of reward:evidence for simultaneous yet separable food-and drug-entrained rhythms in the rat.Chronobiol Int 2012;29:454-468[PMID:22475541 DOI:10.3109/07420528.2012.667467]
22 Mohawk JA,Pezuk P,Menaker M.Methamphetamine and dopamine receptor D1 regulate entrainment of murine circadian oscillators.PLo S One 2013;8:e62463[PMID:23626822 DOI:10.1371/journal.pone.0062463]
23 Vengeliene V,Noori HR,Spanagel R.Activation of Melatonin Receptors Reduces Relapse-Like Alcohol Consumption.Neurops-ychopharmacology 2015;40:2897-2906[PMID:25994077 DOI:10.1038/npp.2015.143]
24 Takahashi TT,Vengeliene V,Spanagel R.Melatonin reduces motivation for cocaine self-administration and prevents relapse-like behavior in rats.Psychopharmacology(Berl)2017;234:1741-1748[PMID:28246896 DOI:10.1007/s00213-017-4576-y]
25 World Health Organization.Neuroscience of psychoactive drug use and dependence.WHO,Geneva Switzerland 2004:1-286.Available from:URL:https://www.naabt.org/documents/Neuroscien ce%20of%20psychoactive.pdf
26 Carter A,Hal L W,Capps B,Daglish M.Neurobiological research on addiction:A review of the scientific,public health and social policy Implications for Australia.2009:1-241.Available from:URL:https://www.nationaldrugstrategy.gov.au/
27 Hyman SE,Malenka RC,Nestler EJ.Neural mechanisms of addiction:the role of reward-related learning and memory.Annu Rev Neurosci 2006;29:565-598[PMID:16776597 DOI:10.1146/annurev.neuro.29.051605.113009]
28 Goldstein RZ,Volkow ND.Drug addiction and its underlying neurobiological basis:neuroimaging evidence for the involvement of the frontal cortex.Am J Psychiatry 2002;159:1642-1652[PMID:12359667 DOI:10.1176/appi.ajp.159.10.1642]
29 Koob GF,Le Moal M.Drug abuse:hedonic homeostatic dysregulation.Science 1997;278:52-58[PMID:9311926 DOI:10.1126/science.278.5335.52]
30 Koob GF,Le Moal M.Addiction and the brain antireward system.Annu Rev Psychol 2008;59:29-53[PMID:18154498 DOI:10.1146/annurev.psych.59.103006.093548]
31 Kreek MJ,Koob GF.Drug dependence:stress and dysregulation of brain reward pathways.Drug Alcohol Depend 1998;51:23-47[PMID:9716928 DOI:10.1016/S0376-8716(98)00064-7]
32 Koob G,Kreek MJ.Stress,dysregulation of drug reward path-ways,and the transition to drug dependence.Am J Psychiatry2007;164:1149-1159[PMID:17671276 DOI:10.1176/appi.ajp.2007.05030503]
33 Koob GF,Le Moal M.Neurobiology of addiction.1st ed.New York:Academic Press,2006
34 Wise RA.Dopamine,learning and motivation.Nat Rev Neurosci2004;5:483-494[PMID:15152198 DOI:10.1038/nrn1406]
35 Volkow ND,Li TK.Drug addiction:the neurobiology of behaviour gone awry.Nat Rev Neurosci 2004;5:963-970[PMID:15550951DOI:10.1038/nrn1539]
36 Wise RA.Dopamine and reward:the anhedonia hypothesis 30years on.Neurotox Res 2008;14:169-183[PMID:19073424 DOI:10.1007/BF03033808]
37 Di Chiara G.Nucleus accumbens shell and core dopamine:differential role in behavior and addiction.Behav Brain Res 2002;137:75-114[PMID:12445717 DOI:10.1016/S0166-4328(02)00286-3]
38 van Ree JM,Gerrits MA,Vanderschuren LJ.Opioids,reward and addiction:An encounter of biology,psychology,and medicine.Pharmacol Rev 1999;51:341-396[PMID:10353987]
39 Feltenstein MW,See RE.Potentiation of cue-induced reinstatement of cocaine-seeking in rats by the anxiogenic drug yohimbine.Behav Brain Res 2006;174:1-8[PMID:16920204 DOI:10.1016/j.bbr.2006.06.039]
40 Brauer LH,De Wit H.High dose pimozide does not block amphetamine-induced euphoria in normal volunteers.Pharmacol Biochem Behav 1997;56:265-272[PMID:9050084 DOI:10.1016/S0091-3057(96)00240-7]
41 Goodman A.Neurobiology of addiction.An integrative review.Biochem Pharmacol 2008;75:266-322[PMID:17764663 DOI:10.1016/j.bcp.2007.07.030]
42 Heinz A,Reimold M,Wrase J,Hermann D,Croissant B,Mundle G,Dohmen BM,Braus DF,Schumann G,Machulla HJ,Bares R,Mann K.Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving:a positron emission tomography study using carbon 11-labeled carfentanil.Arch Gen Psychiatry 2005;62:57-64[PMID:15630073DOI:10.1001/archpsyc.62.1.57]
43 Williams TM,Daglish MR,Lingford-Hughes A,Taylor LG,Hammers A,Brooks DJ,Grasby P,Myles JS,Nutt DJ.Brain opioid receptor binding in early abstinence from opioid dependence:positron emission tomography study.Br J Psychiatry 2007;191:63-69[PMID:17602127 DOI:10.1192/bjp.bp.106.031120]
44 Zubieta JK,Gorelick DA,Stauffer R,Ravert HT,Dannals RF,Frost JJ.Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving.Nat Med1996;2:1225-1229[PMID:8898749 DOI:10.1038/nm1196-1225]
45 Kalivas PW,Lalumiere RT,Knackstedt L,Shen H.Glutamate transmission in addiction.Neuropharmacology 2009;56 Suppl 1:169-173[PMID:18675832 DOI:10.1016/j.neuropharm.2008.07.011]
46 Hochhauser M.Chronobiological Factors in Drug Abuse.A.J.Schecter(ed.).Drug Dependence and Alcoholism.New York:Plenum Press,1981:855-864
47 Hasler BP,Smith LJ,Cousins JC,Bootzin RR.Circadian rhythms,sleep,and substance abuse.Sleep Med Rev 2012;16:67-81[PMID:21620743 DOI:10.1016/j.smrv.2011.03.004]
48 Garmabi B,Vousooghi N,Vosough M,Yoonessi A,Bakhtazad A,Zarrindast MR.Effect of circadian rhythm disturbance on morphine preference and addiction in male rats:Involvement of period genes and dopamine D1 receptor.Neuroscience 2016;322:104-114[PMID:26892296 DOI:10.1016/j.neuroscience.2016.02.019]
49 Doyle SE,Feng H,Garber G,Menaker M,Lynch WJ.Effects of circadian disruption on methamphetamine consumption in meth-amphetamine-exposed rats.Psychopharmacology(Berl)2015;232:2169-2179[PMID:25543849 DOI:10.1007/s00213-014-3845-2]
50 Parekh PK,Ozburn AR,Mc Clung CA.Circadian clock genes:effects on dopamine,reward and addiction.Alcohol 2015;49:341-349[PMID:25641765 DOI:10.1016/j.alcohol.2014.09.034]
51 Schierenbeck T,Riemann D,Berger M,Hornyak M.Effect of illicit recreational drugs upon sleep:cocaine,ecstasy and marijuana.Sleep Med Rev 2008;12:381-389[PMID:18313952 DOI:10.1016/j.smrv.2007.12.004]
52 Brower KJ.Alcohol's effects on sleep in alcoholics.Alcohol Res Health 2001;25:110-125[PMID:11584550]
53 Baker TB,Piper ME,Mc Carthy DE,Majeskie MR,Fiore MC.Addiction motivation reformulated:an affective processing model of negative reinforcement.Psychol Rev 2004;111:33-51[PMID:14756584 DOI:10.1037/0033-295X.111.1.33]
54 Thompson PM,Gillin JC,Golshan S,Irwin M.Polygraphic sleep measures differentiate alcoholics and stimulant abusers during short-term abstinence.Biol Psychiatry 1995;38:831-836[PMID:8750043 DOI:10.1016/0006-3223(95)00070-4]
55 Morgan PT,Pace-Schott E,Pittman B,Stickgold R,Malison RT.Normalizing effects of modafinil on sleep in chronic cocaine users.Am J Psychiatry 2010;167:331-340[PMID:20080983 DOI:10.1176/appi.ajp.2009.09050613]
56 Bolla KI,Lesage SR,Gamaldo CE,Neubauer DN,Wang NY,Funderburk FR,Allen RP,David PM,Cadet JL.Polysomnogram changes in marijuana users who report sleep disturbances during prior abstinence.Sleep Med 2010;11:882-889[PMID:20685163DOI:10.1016/j.sleep.2010.02.013]
57 Fraschini F,Cesarani A,Alpini D,Esposti D,Stankov BM.Mela-tonin influences human balance.Biol Signals Recept 1999;8:111-119[PMID:10085472 DOI:10.1159/000014578]
58 Reiter RJ.Melatonin:clinical relevance.Best Pract Res Clin Endocrinol Metab 2003;17:273-285[PMID:12787552 DOI:10.1016/S1521-690X(03)00016-2]
59 Hardeland R,Cardinali DP,Srinivasan V,Spence DW,Brown GM,Pandi-Perumal SR.Melatonin-a pleiotropic,orchestrating regulator molecule.Prog Neurobiol 2011;93:350-384[PMID:21193011DOI:10.1016/j.pneurobio.2010.12.004]
60 Ekmekcioglu C.Melatonin receptors in humans:biological role and clinical relevance.Biomed Pharmacother 2006;60:97-108[PMID:16527442 DOI:10.1016/j.biopha.2006.01.002]
61 Jockers R,Maurice P,Boutin JA,Delagrange P.Melatonin receptors,heterodimerization,signal transduction and binding sites:what's new?Br J Pharmacol 2008;154:1182-1195[PMID:18493248 DOI:10.1038/bjp.2008.184]
62 Pandi-Perumal SR,Trakht I,Srinivasan V,Spence DW,Maestroni GJ,Zisapel N,Cardinali DP.Physiological effects of melatonin:role of melatonin receptors and signal transduction pathways.Prog Neurobiol 2008;85:335-353[PMID:18571301 DOI:10.1016/j.pneurobio.2008.04.001]
63 Habtemariam S,Daglia M,Sureda A,Selamoglu Z,Gulhan MF,Nabavi SM.Melatonin and Respiratory Diseases:A Review.Curr Top Med Chem 2017;17:467-488[PMID:27558675 DOI:10.2174/1568026616666160824120338]
64 Ate?B,Y?lmaz HR,Selamo?lu Z,Iraz M,Y?lmaz?.Melatonin’in?ntestinal?skemi-Reperfüzyonda 6-Fosfoglukonat Dehidrogenaz Aktivitesiüzerine Etkisi.Süleyman Demirelüniversitesi T?p Fakültesi Dergisi 2004;11:8-11
65 Tas U,Ayan M,Sogut E,Kuloglu T,Uysal M,Tanriverdi HI,Senel U,Ozyurt B,Sarsilmaz M.Protective effects of thymoquinone and melatonin on intestinal ischemia-reperfusion injury.Saudi JGastroenterol 2015;21:284-289[PMID:26458854 DOI:10.4103/1319-3767.166203]
66 Kühlwein E,Hauger RL,Irwin MR.Abnormal nocturnal melatonin secretion and disordered sleep in abstinent alcoholics.Biol Psychiatry 2003;54:1437-1443[PMID:14675809 DOI:10.1016/S0006-3223(03)00005-2]
67 Peres R,do Amaral FG,Madrigrano TC,Scialfa JH,Bordin S,Afeche SC,Cipolla-Neto J.Ethanol consumption and pineal melatonin daily profile in rats.Addict Biol 2011;16:580-590[PMID:21635669 DOI:10.1111/j.1369-1600.2011.00342.x]
68 Uz T,Javaid JI,Manev H.Circadian differences in behavioral sensitization to cocaine:putative role of arylalkylamine N-ace-tyltransferase.Life Sci 2002;70:3069-3075[PMID:12138020 DOI:10.1016/S0024-3205(02)01559-X]
69 Kurtuncu M,Arslan AD,Akhisaroglu M,Manev H,Uz T.Invol-vement of the pineal gland in diurnal cocaine reward in mice.Eur JPharmacol 2004;489:203-205[PMID:15087244 DOI:10.1016/j.ejphar.2004.03.010]
70 Williams RL,Soliman KF,Mizinga KM.Circadian variation in tolerance to the hypothermic action of CNS drugs.Pharmacol Biochem Behav 1993;46:283-288[PMID:8265682 DOI:10.1016/0091-3057(93)90354-V]
71 Drummond SP,Gillin JC,Smith TL,De Modena A.The sleep of abstinent pure primary alcoholic patients:natural course and relationship to relapse.Alcohol Clin Exp Res 1998;22:1796-1802[PMID:9835298 DOI:10.1097/00000374-199811000-00026]
72 Lax P.Melatonin inhibits nicotinic currents in cultured rat cerebellar granule neurons.J Pineal Res 2008;44:70-77[PMID:18078451DOI:10.1111/j.1600-079X.2007.00481.x]
73 Markus RP,Santos JM,Zago W,Reno LA.Melatonin nocturnal surge modulates nicotinic receptors and nicotine-induced[3H]glutamate release in rat cerebellum slices.J Pharmacol Exp Ther 2003;305:525-530[PMID:12606693 DOI:10.1124/jpet.102.045625]
74 Onaolapo OJ,Onaolapo AY.Melatonin,adolescence,and the brain:An insight into the period-specific influences of a multifunctional signaling molecule.Birth Defects Res 2017;109:1659-1671[PMID:29251845 DOI:10.1002/bdr2.1171]
75 Onaolapo OJ,Onaolapo AY.Chapter 4.Melatonin Receptors,Behaviour and Brain Function.Lore Correia and Germaine Mayers(Eds)in Melatonin:Medical Uses and Role in Health and Disease2018:133-158
76 Uz T,Arslan AD,Kurtuncu M,Imbesi M,Akhisaroglu M,Dwivedi Y,Pandey GN,Manev H.The regional and cellular expression profile of the melatonin receptor MT1 in the central dopaminergic system.Brain Res Mol Brain Res 2005;136:45-53[PMID:15893586 DOI:10.1016/j.molbrainres.2005.01.002]
77 Noori HR,Spanagel R,Hansson AC.Neurocircuitry for modeling drug effects.Addict Biol 2012;17:827-864[PMID:22978651 DOI:10.1111/j.1369-1600.2012.00485.x]
78 Imbesi M,Uz T,Yildiz S,Arslan AD,Manev H.Drug-and region-specific effects of protracted antidepressant and cocaine treatment on the content of melatonin MT(1)and MT(2)receptor m RNA in the mouse brain.Int J Neuroprot Neuroregener 2006;2:185-189[PMID:18389085]
79 Hutchinson AJ,Hudson RL,Dubocovich ML.Genetic deletion of MT(1)and MT(2)melatonin receptors differentially abrogates the development and expression of methamphetamine-induced locomotor sensitization during the day and the night in C3H/He Nmice.J Pineal Res 2012;53:399-409[PMID:22672659 DOI:10.1111/j.1600-079X.2012.01010.x]
80 Clough SJ,Hutchinson AJ,Hudson RL,Dubocovich ML.Genetic deletion of the MT1 or MT2 melatonin receptors abrogates methamphetamine-induced reward in C3H/He N mice.Physiol Behav 2014;132:79-86[PMID:24813704 DOI:10.1016/j.ph-ysbeh.2014.04.049]
81 Hutchinson AJ,Ma J,Liu J,Hudson RL,Dubocovich ML.Role of MT1 melatonin receptors in methamphetamine-induced locomotor sensitization in C57BL/6 mice.Psychopharmacology(Berl)2014;231:257-267[PMID:23934259 DOI:10.1007/s00213-013-3228-0]
82 Zahn PK,Lansmann T,Berger E,Speckmann EJ,Musshoff U.Gene expression and functional characterization of melatonin receptors in the spinal cord of the rat:implications for pain modulation.JPineal Res 2003;35:24-31[PMID:12823610 DOI:10.1034/j.1600-079X.2003.00047.x]
83 Sinha R.New findings on biological factors predicting addiction relapse vulnerability.Curr Psychiatry Rep 2011;13:398-405[PMID:21792580 DOI:10.1007/s11920-011-0224-0]
84 Feng YM,Jia YF,Su LY,Wang D,Lv L,Xu L,Yao YG.Decreased mitochondrial DNA copy number in the hippocampus and peripheral blood during opiate addiction is mediated by autophagy and can be salvaged by melatonin.Autophagy 2013;9:1395-1406[PMID:23800874 DOI:10.4161/auto.25468]
85 Sircar R.Effect of melatonin on cocaine-induced behavioral sensitization.Brain Res 2000;857:295-299[PMID:10700581 DOI:10.1016/S0006-8993(99)02460-9]
86 Peles E,Hetzroni T,Bar-Hamburger R,Adelson M,Schreiber S.Melatonin for perceived sleep disturbances associated with benzodiazepine withdrawal among patients in methadone mai-ntenance treatment:a double-blind randomized clinical trial.Addiction 2007;102:1947-1953[PMID:17916225 DOI:10.1111/j.1360-0443.2007.02007.x]
87 Dimsdale JE,Norman D,De Jardin D,Wallace MS.The effect of opioids on sleep architecture.J Clin Sleep Med 2007;3:33-36[PMID:17557450]
88 Wang Q,Yue XF,Qu WM,Tan R,Zheng P,Urade Y,Huang ZL.Morphine inhibits sleep-promoting neurons in the ventrolateral preoptic area via mu receptors and induces wakefulness in rats.Neuropsychopharmacology 2013;38:791-801[PMID:23303062DOI:10.1038/npp.2012.244]
89 Licata SC,Renshaw PF.Neurochemistry of drug action:insights from proton magnetic resonance spectroscopic imaging and their relevance to addiction.Ann N Y Acad Sci 2010;1187:148-171[PMID:20201852 DOI:10.1111/j.1749-6632.2009.05143.x]
90 Gossop M,Bradley B,Phillips GT.An investigation of withdrawal symptoms shown by opiate addicts during and subsequent to a 21-day in-patient methadone detoxification procedure.Addict Behav 1987;12:1-6[PMID:3565107 DOI:10.1016/0306-4603(87)90002-5]
91 Pjrek E,Frey R,Naderi-Heiden A,Strnad A,Kowarik A,Kasper S,Winkler D.Actigraphic measurements in opioid detoxification with methadone or buprenorphine.J Clin Psychopharmacol 2012;32:75-82[PMID:22198453 DOI:10.1097/JCP.0b013e31823f91d1]
92 Hood S,Cassidy P,Mathewson S,Stewart J,Amir S.Daily morphine injection and withdrawal disrupt 24-h wheel running and PERIOD2 expression patterns in the rat limbic forebrain.Neuroscience 2011;186:65-75[PMID:21536108 DOI:10.1016/j.neuroscience.2011.04.045]
93 Glaser AM,Reyes-Vázquez C,Prieto-Gómez B,Burau K,Dafny N.Morphine administration and abrupt cessation alter the behavioral diurnal activity pattern.Pharmacol Biochem Behav 2012;101:544-552[PMID:22386964 DOI:10.1016/j.pbb.2012.02.015]
94 Li SX,Liu LJ,Jiang WG,Lu L.Morphine withdrawal produces circadian rhythm alterations of clock genes in mesolimbic brain areas and peripheral blood mononuclear cells in rats.J Neu-rochem 2009;109:1668-1679[PMID:19383088 DOI:10.1111/j.1471-4159.2009.06086.x]
95 Li SX,Liu LJ,Jiang WG,Sun LL,Zhou SJ,Le Foll B,Zhang XY,Kosten TR,Lu L.Circadian alteration in neurobiology during protr-acted opiate withdrawal in rats.J Neurochem 2010;115:353-362[PMID:20738730 DOI:10.1111/j.1471-4159.2010.06941.x]
96 Zhdanova IV,Giorgetti M.Melatonin alters behavior and c AMPlevels in nucleus accumbens induced by cocaine treatment.Brain Res 2002;956:323-331[PMID:12445702 DOI:10.1016/S0006-8993(02)03565-5]
97 Bondi CD,Kamal KM,Johnson DA,Witt-Enderby PA,Giannetti VJ.The Effect of Melatonin Upon Postacute Withdrawal Among Males in a Residential Treatment Program(M-PAWS):A Randomized,Double-blind,Placebo-controlled Trial.J Addict Med 2018;12:201-206[PMID:29351138 DOI:10.1097/ADM.0000000000000386]
98 Cemek M,Büyükokuro?lu ME,Hazman?,Bulut S,Konuk M,Birdane Y.Antioxidant enzyme and element status in heroin addiction or heroin withdrawal in rats:effect of melatonin and vitamin E plus Se.Biol Trace Elem Res 2011;139:41-54[PMID:20180043 DOI:10.1007/s12011-010-8634-0]
99 O'Brien CP.Anticraving medications for relapse prevention:a possible new class of psychoactive medications.Am J Psychiatry2005;162:1423-1431[PMID:16055763 DOI:10.1176/appi.ajp.162.8.1423]
100 Kalivas PW,O'Brien C.Drug addiction as a pathology of staged neuroplasticity.Neuropsychopharmacology 2008;33:166-180[PMID:17805308 DOI:10.1038/sj.npp.1301564]
101 Sinha R,Shaham Y,Heilig M.Translational and reverse tran-slational research on the role of stress in drug craving and relapse.Psychopharmacology(Berl)2011;218:69-82[PMID:21494792DOI:10.1007/s00213-011-2263-y]
102 Sinha R.How does stress increase risk of drug abuse and relapse?Psychopharmacology(Berl)2001;158:343-359[PMID:11797055DOI:10.1007/s002130100917]
103 Jaffe JH,Cascella NG,Kumor KM,Sherer MA.Cocaine-induced cocaine craving.Psychopharmacology(Berl)1989;97:59-64[PMID:2496428 DOI:10.1007/BF00443414]
104 O’Brien CP,Ehrman RN,Ternes JW.Classical conditioning in human opioid dependence.In:Behavioral analysis of drug dependence(Goldberg S,Stolerman I,eds).Orlando,FL:Academic,1986:329-356
105 Wikler A.Dynamics of drug dependence.Implications of a conditioning theory for research and treatment.Arch Gen Psy-chiatry 1973;28:611-616[PMID:4700675 DOI:10.1001/arc-hpsyc.1973.01750350005001]
106 Bossert JM,Marchant NJ,Calu DJ,Shaham Y.The reinstatement model of drug relapse:recent neurobiological findings,emerging research topics,and translational research.Psychopharmacology(Berl)2013;229:453-476[PMID:23685858 DOI:10.1007/s00213-013-3120-y]
107 Mantsch JR,Baker DA,Funk D,LêAD,Shaham Y.Stress-Induced Reinstatement of Drug Seeking:20 Years of Progress.Neuropsychopharmacology 2016;41:335-356[PMID:25976297DOI:10.1038/npp.2015.142]
108 Dong Y,Taylor JR,Wolf ME,Shaham Y.Circuit and Synaptic Plasticity Mechanisms of Drug Relapse.J Neurosci 2017;37:10867-10876[PMID:29118216 DOI:10.1523/JNEUROSCI.1821-17.2017]
109 Bhargava HN,Kumar S.Sensitization to the locomotor stimulant activity of cocaine is associated with increases in nitric oxide synthase activity in brain regions and spinal cord of mice.Pharmacology 1997;55:292-298[PMID:9413858 DOI:10.1159/000139541]
110 Itzhak Y,Martin JL,Black MD,Ali SF.Effect of melatonin on methamphetamine-and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity and methamphetamine-induced behavioral sensitization.Neuropharmacology 1998;37:781-791[PMID:9707292 DOI:10.1016/S0028-3908(98)00067-7]
111 Patkar AA,Rozen S,Mannelli P,Matson W,Pae CU,Krishnan KR,Kaddurah-Daouk R.Alterations in tryptophan and purine metabolism in cocaine addiction:a metabolomic study.Psychopharmacology(Berl)2009;206:479-489[PMID:19649617 DOI:10.1007/s00213-009-1625-1]
112 Cunha-Oliveira T,Rego AC,Garrido J,Borges F,Macedo T,Oliveira CR.Street heroin induces mitochondrial dysfunction and apoptosis in rat cortical neurons.J Neurochem 2007;101:543-554[PMID:17250679 DOI:10.1111/j.1471-4159.2006.04406.x]
113 Lin X,Wang YJ,Li Q,Hou YY,Hong MH,Cao YL,Chi ZQ,Liu JG.Chronic high-dose morphine treatment promotes SH-SY5Ycell apoptosis via c-Jun N-terminal kinase-mediated activation of mitochondria-dependent pathway.FEBS J 2009;276:2022-2036[PMID:19292871 DOI:10.1111/j.1742-4658.2009.06938.x]
114 Cunha-Oliveira T,Rego AC,Oliveira CR.Cellular and molec-ular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs.Brain Res Rev 2008;58:192-208[PMID:18440072 DOI:10.1016/j.brainresrev.2008.03.002]
115 Bolla KI,Lesage SR,Gamaldo CE,Neubauer DN,Funderburk FR,Cadet JL,David PM,Verdejo-Garcia A,Benbrook AR.Sleep disturbance in heavy marijuana users.Sleep 2008;31:901-908[PMID:18548836 DOI:10.1093/sleep/31.6.901]
116 Brower KJ,Conroy DA,Kurth ME,Anderson BJ,Stein MD.Ramelteon and improved insomnia in alcohol-dependent patients:a case series.J Clin Sleep Med 2011;7:274-275[PMID:21677897DOI:10.5664/JCSM.1070]
117 Roehrs T,Roth T.Sleep,sleepiness,sleep disorders and alcohol use and abuse.Sleep Med Rev 2001;5:287-297[PMID:12530993 DOI:10.1053/smrv.2001.0162]
118 Colrain IM,Trinder J,Swan GE.The impact of smoking cessation on objective and subjective markers of sleep:review,synthesis,and recommendations.Nicotine Tob Res 2004;6:913-925[PMID:15801567 DOI:10.1080/14622200412331324938]
119 Schreiber S.[Benzodiazepines--update].Harefuah 1993;125:172-174[PMID:7901131]
120 Clasadonte J,Mc Iver SR,Schmitt LI,Halassa MM,Haydon PG.Chronic sleep restriction disrupts sleep homeostasis and behavioral sensitivity to alcohol by reducing the extracellular accumulation of adenosine.J Neurosci 2014;34:1879-1891[PMID:24478367 DOI:10.1523/JNEUROSCI.2870-12.2014]
121 Comasco E,Nordquist N,G?ktürk C,Aslund C,Hallman J,Oreland L,Nilsson KW.The clock gene PER2 and sleep problems:association with alcohol consumption among Swedish adolescents.Ups J Med Sci 2010;115:41-48[PMID:20187847 DOI:10.3109/03009731003597127]
122 Spanagel R,Rosenwasser AM,Schumann G,Sarkar DK.Alcohol consumption and the body's biological clock.Alcohol Clin Exp Res 2005;29:1550-1557[PMID:16156052 DOI:10.1097/01.alc.0000175074.70807.fd]
123 Wang X,Mozhui K,Li Z,Mulligan MK,Ingels JF,Zhou X,Hori RT,Chen H,Cook MN,Williams RW,Lu L.A promoter polymorphism in the Per3 gene is associated with alcohol and stress response.Transl Psychiatry 2012;2:e73[PMID:22832735 DOI:10.1038/tp.2011.71]
124 Cajochen C,Kr?uchi K,Wirz-Justice A.Role of melatonin in the regulation of human circadian rhythms and sleep.J Neu-roendocrinol 2003;15:432-437[PMID:12622846 DOI:10.1046/j.1365-2826.2003.00989.x]
125 Shamir E,Laudon M,Barak Y,Anis Y,Rotenberg V,Elizur A,Zisapel N.Melatonin improves sleep quality of patients with chronic schizophrenia.J Clin Psychiatry 2000;61:373-377[PMID:10847313 DOI:10.4088/JCP.v61n0509]
126 Garfinkel D,Laudon M,Nof D,Zisapel N.Improvement of sleep quality in elderly people by controlled-release melatonin.Lancet 1995;346:541-544[PMID:7658780 DOI:10.1016/S0140-6736(95)91382-3]
127 Garfinkel D,Zisapel N,Wainstein J,Laudon M.Facilitation of benzodiazepine discontinuation by melatonin:a new clinical approach.Arch Intern Med 1999;159:2456-2460[PMID:10665894DOI:10.1001/archinte.159.20.2456]
128 Smits MG,Nagtegaal EE,van der Heijden J,Coenen AM,Kerkhof GA.Melatonin for chronic sleep onset insomnia in children:a randomized placebo-controlled trial.J Child Neurol 2001;16:86-92[PMID:11292231 DOI:10.1177/088307380101600204]
129 Wetterberg L,Aperia B,Gorelick DA,Gwirtzman HE,Mc Guire MT,Serafetinides EA,Yuwiler A.Age,alcoholism and depression are associated with low levels of urinary melatonin.J Psychiatry Neurosci 1992;17:215-224[PMID:1489763]
130 Grosshans M,Mutschler J,Luderer M,Mann K,Kiefer F.Agomelatine is effective in reducing insomnia in abstinent alcohol-dependent patients.Clin Neuropharmacol 2014;37:6-8[PMID:24434525 DOI:10.1097/WNF.0000000000000007]